Validation, Calibration, and Standardization in the Life Sciences Market

Report Code: BIO179B

Publish Date: Mar 2026

Publisher: BCC Publishing

Category: Cell Biology

Download Report Overview

CUSTOMIZE NOW

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

Report Includes

  • 52 data tables and 48 additional tables
  • Overview and an analysis of the global markets for flexible printed circuit boards (FPCB) technology
  • Analyses of global market trends, with market revenue data for 2024, estimates for 2025, forecast for 2027, and projected CAGRs through 2030
  • Estimates of the size and revenue prospects for global flexible PCB market, along with a corresponding market share analysis by type, layer, application, end-use industry, and geographic region
  • Facts and figures about the global market dynamics, technological advancements, emerging applications, innovations, prospects, regulations, and the impact of macroeconomic factors
  • Insights derived from the Porter’s Five Forces model, as well as global supply chain analyses
  • Analysis of patents, emerging trends and new developments in the electronics manufacturing industry
  • Analysis of the industry structure, including companies’ market shares and rankings, strategic initiatives, M&A activity and a venture funding outlook
  • Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG risk ratings scores and practices of leading companies
  • Company profiles of major players within the industry, including Thermo Fisher Scientific, SGS SA, Trescal, ValGenesis Inc., and Transcat Inc.

Report Scope

The report analyzes the trends in the global market for validation, calibration, and standardization in life sciences. It includes global revenue ($ millions) for the base year of 2024 and estimated data for the forecast period 2025 through 2030. The market is segmented by service provider (in-house, third-party, original equipment manufacturer (OEM), service type (electrotechnical, mechanical, thermal, pressure, pipette, fluid flow/optical, others), product type, and end user. Product type consists of instruments and consumables. Instruments are further segmented into biochemistry analyzers, pH meters, pressure and temperature calibrators, and conductivity meters. Consumables are segmented into calibration kits/sampling kits, glassware, filters, slides, and other items. End users consist of pharmaceutical and biotech companies, research laboratories, contract research organizations, and clinics and hospitals. The regions covered in this study are North America, Europe, Asia-Pacific, the Middle East and Africa, and South America, with analysis of the markets in the U.S., Canada, Mexico, Germany, the U.K., Italy, France, Spain, the Rest of Europe, China, Japan, India, South Korea, and the Rest of Asia-Pacific.

The report focuses on the trends and challenges that affect the market. It includes an analysis of the competitive landscape, with the ranking of leading companies and their market shares. It offers company profiles that cover financials, product portfolios, and recent developments.

Report Synopsis

Report Metrics Details
Base year considered 2024
Forecast period considered 2025-2030
Base year market size $2.7 billion
Market size forecast $3.9 billion
Growth rate CAGR of 6.7% for the forecast period of 2025-2030
Units considered $ Millions
Segments covered Service Provider, Service Type, Product Type, End User
Regions covered North America, Europe, Asia-Pacific, Rest of the World
Countries covered U.S., Canada, Mexico, France, Germany, U.K., Italy, Spain, Switzerland, the Netherlands, Belgium, the Nordics, and Eastern Europe, China, India, Japan, South Korea, Singapore, Malaysia, Thailand, Indonesia, Vietnam, Taiwan, South America, Middle East and Africa
Key Market Drivers
  • Regulatory Compliance Requirements
  • Proliferation of Complex Biologics and Advanced Therapy Medicinal Products (ATMPs)
  • Digital Transformation and Industry 4.0 in Life Sciences
Companies studied
ADVANTEST CORP.BECKMAN COULTER INC.
CROSS CO.DASSAULT SYSTEMES
ENDRESS+HAUSER GROUP SERVICES AGHARVARD BIOSCIENCE INC.
IBM CORP.INSIGHT CALIBRATION SERVICES INC.
SGS Societe Generale de Surveillance SATEKTRONIX INC.
THERMO FISHER SCIENTIFIC INC.TRANSCAT INC.
TRESCALVAISALA
VALGENESIS INC.
Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS

Frequently Asked Questions (FAQs)

The estimated market size for validation, calibration, and standardization in life sciences market is $3.9 billion by the end of 2030. The CAGR is 6.7%.
  • Regulatory compliance requirements.
  • The proliferation of complex biologics and advanced therapies medicinal products (ATMPs).
  • Digital transformation and Industry 4.0 in life sciences.
  • Key challenges include - High cost associated with advanced calibration verification solutions, Limited availability of specialized technical and regulatory expertise.
  • Key opportunities include - AI-Driven Validation & Predictive Quality Platforms, Digital Validation Lifecycle Management (VLMS / VLM) Systems, Cloud-Based Compliance Platforms & Remote Validation.
The market is segmented by service provider, by service type, by product type, end user, and region.
The In-house segment will continue to dominate the market by the end of 2030, driven by large pharmaceutical and biotechnology companies maintaining internal quality and metrology teams to ensure data integrity, expedite turnaround times, and maintain regulatory compliance.
North America has the highest market share, driven by the strength of the FDA, GMP, ISO 17025 regulatory compliance, considerable biopharma research and development programs, and the general acceptance of digital validation tools by Thermo Fisher Scientific, ValGenesis, and Transcat.

Analyst Credentials

BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.

Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Validation, Calibration, and Standardization in the Life Sciences Market129Free
Chapter- 1: Executive Summary5Free
Chapter- 2: Market Overview5Free
Chapter- 3: Market Dynamics6Free
Chapter- 4: Regulatory Landscape4Free
Chapter- 5: Emerging Technologies and Developments3Free
Chapter- 6: Market Segmentation Analysis54Free
Chapter- 7: Competitive Intelligence5Free
Chapter- 8: Appendix47Free

Related Reports

Single-use Technologies for Biopharmaceuticals: Global Markets

Published - Nov 2024 | Publisher - BCC Publishing | Code - BIO099F

The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.

Analytical Laboratory Instruments Manufacturing: Global Markets

Published - Jan 2024 | Publisher - Harsh Goyal | Code - IAS130B

The global market for analytical laboratory instruments is estimated to increase from $60.9 billion in 2023 to reach $82.5 billion by 2028, at a compound annual growth rate (CAGR) of 6.3% from 2023 through 2028.

Biosensors and Nanosensors: Global Markets and Technologies

Published - Jan 2024 | Publisher - Austin Samuel | Code - IAS128B

The global market for biosensors and nanosensors is expected to grow from $30.6 billion in 2023 to $43.5 billion by 2028, at a compound annual growth rate (CAGR) of 7.3% from 2023 to 2028.

Biologics Development and Manufacturing Testing: Technologies and Global Markets

Published - Mar 2023 | Publisher - BCC Publishing | Code - BIO155B

The global market for biologics safety testing is estimated to increase from $7.4 billion in 2022 to reach $18.2 billion by 2027, at a compound annual growth rate (CAGR) of 19.9% from 2022 through 2027.

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 100

  • Summary Table: Global Market for Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
  • Table 1: Global Market for Validation, Calibration, and Standardization in Life Sciences, by Service Provider, Through 2030
  • Table 2: Global Market for In-House Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
  • Table 3: Global Market for Third-Party Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
  • Table 4: Global Market for OEM Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
  • Table 5: Global Market for Validation, Calibration, and Standardization in Life Sciences, by Service Type, Through 2030
  • Table 6: Global Market for Electrotechnical Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
  • Table 7: Global Market for Mechanical Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
  • Table 8: Global Market for Thermal Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
  • Table 9: Global Market for Pressure Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
  • Table 10: Global Market for Pipette Validation, Calibration, and Standardization in Life Sciences, by Region, Through 2030
Sample Report

Recent Reports

Global DNA Read, Write, and Edit Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - BIO193B

The global market for DNA read, write, and edit was valued at $25.9 billion in 2025 and is estimated to reach $67.7 billion by 2030, at a compound annual growth rate (CAGR) of 21.2% from 2025 through 2030.

Validation, Calibration, and Standardization in the Life Sciences Market

Published - Mar 2026 | Publisher - BCC Publishing | Code - BIO179B

The global market for validation, calibration, and standardization in life sciences was valued at $2.8 billion in 2025 and is estimated to reach $3.9 billion by 2030, at a compound annual growth rate (CAGR) of 6.7% from 2025 through 2030.

Cloud Computing in Cell Biology, Genomics and Drug Development: Global Markets

Published - Feb 2026 | Publisher - BCC Publishing | Code - BIO200B

The global market for cloud computing in cell biology, genomics and drug development is estimated to grow from $7.2 billion in 2025 to $15.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 16.7% from 2025 through 2030.

Decentralized Clinical Trials: Global Markets

Published - Feb 2026 | Publisher - BCC Publishing | Code - BIO275A

The report provides an overview of the global decentralized clinical trials (DCT) market and analyzes market trends. It includes global revenue ($ Million) for the base year data of 2024 and for the forecast period 2025 through 2030.

Central Nervous System (CNS) Biomarkers: Technologies and Global Markets

Published - Feb 2026 | Publisher - BCC Publishing | Code - BIO074E

The global market for central nervous system (CNS) biomarkers is estimated to grow from $7.6 billion in 2025 to reach $13.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.6% from 2025 through 2030.

Top Trending Reports

Stem Cell and Regenerative Therapy: Global Markets

Published - Feb 2026 | Publisher - BCC Publishing | Code - BIO191B

The global market for stem cell and regenerative therapy is projected to grow from an estimated $16.7 billion in 2025 to $43.8 billion by 2030, at a compound annual growth rate (CAGR) of 21.3% from 2025 to 2030.

Bioprocess Filtration: Global Markets

Published - Oct 2025 | Publisher - BCC Publishing | Code - MDS043B

The global market for bioprocess filtration is estimated to grow from $8.4 billion in 2025 to reach $15.6 billion by 2030, at a compound annual growth rate (CAGR) of 13.1% from 2025 through 2030.

Cell and Gene Therapy Tools and Reagents: Global Markets

Published - Feb 2026 | Publisher - BCC Publishing | Code - BIO208D

The global market for cell and gene therapy tools and reagents is expected to grow from $12 billion in 2025 and is projected to reach $19.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 10.6% during the forecast period of 2025 to 2030.

State of the Energy & Sustainability Industry - Fourth Quarter Review

Published - Jan 2026 | Publisher - BCC Publishing | Code - EGY206B

State of the Energy & Sustainability Industry Market Report highlights key trends, clean energy growth, sustainability initiatives, and future market outlook worldwide.

Molecular Diagnostics: Technologies and Global Markets

Published - Sep 2025 | Publisher - BCC Publishing | Code - BIO063F

The global market for molecular diagnostics is expected to grow from $23 billion in 2025 and is projected to reach $42.6 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.1% during the forecast period of 2025 to 2030.

Published - May-2019| Analyst - Sathya Durga| Code - BIO179A

Report Highlights

The global market for validation, calibration and standardization in the global life sciences should grow from $1.5 billion in 2018 to reach $2.1 billion by 2023 at a compound annual growth rate (CAGR) of 6.7% for the period of 2018-2023.

Report Includes 

  • 85 data tables and 50 additional tables
  • Country specific data and analysis for US, Canada, Germany, France, UK, Spain, China, India, Japan, and Australia
  • Explanation of validation and calibration of instruments such as heap filters, pH meters, incubators, autoclaves, HPLC units, and GC units
  • Discussion of ongoing research in treatments of various diseases and susceptibility of various microbes toward traditional medicines as driving factors to the industry
  • Insight into the regulatory compliances in life science industry
  • Detailed profile of major companies of the industry, including Beckman Coulter, Inc., Biovia (Dassault Systems), Data Sciences International (DSI), IBM and Thermo Fisher Scientific

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Validation, Calibration, and Standardization in the Life Sciences Market
Sample Report
AI Sentiment